Health

Researchers found a lower risk of colorectal cancer in women who started endoscopy screenings at age 45 compared to those who had not undergone screening at all.

A fourth disorder that causes dementia has been added to the list. It’s called LATE and is estimated to cause about 15 to 20 percent of all dementias.

Harvard experts say breaking an unhealthy habit can be done. It takes intent, a little white-knuckling, and some effective behavior modification techniques.

A new study shows the impact of early amyloid-β and tau protein accumulation on disrupting brain connections important for memory. These disrupted connections were present even before signs of cognitive impairment were observed.

Researchers have found that “brain water” can exit through tiny channels to reach the skull’s bone marrow, which can detect infection or injury.

Harvard scientists give their read on recent COVID data from the U.S. and South Africa.

Psychiatric epidemiologist warns crisis too recent for conclusive results but shares some surprising, troubling early indications.

Neuroscientist says the jury’s still out on effects on neurodevelopment of fetuses, teens.

A new study by Harvard-affiliated researchers finds that patients with Alzheimer’s disease have both more and different somatic mutations — alterations in DNA — in their brain cells than people without Alzheimer’s disease.

A new study finds that a woman’s history of infertility is associated with increased risk of heart failure.

Newly developed polygenic risk scores, which add up hundreds or thousands of genetic risk factors for six common diseases, can aid physicians and patients in making individualized disease screening and prevention decisions.

Sometimes language problems — also known as aphasia — are the first symptom of progressive brain disorders.

Diversity in U.S. medicine is not keeping pace with population changes, particularly among Black men, according to a new report.

Five former CDC directors convened for a panel about the future of the agency.

A Harvard study finds that people who eat two or more servings of avocado each week may lower their risk of cardiovascular disease compared to people who rarely eat avocado.

Research, experience point to cancer link and other risks, suggesting standard time would be better year-round choice.

A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.

Harvard experts say loneliness, isolation raise risk of depression, anxiety, heart ills.

Scientists conducted a simulation study that projected the future of the COVID-19 pandemic in every state.

Halving deaths and other Biden goals are in reach, experts say, but let’s forget about “moonshot” and focus on resources and prevention.

A new study provides clarity when comparing short-term differences following a traditional vs. robotic-assisted radical prostatectomy.

A large study challenges the theory that light alcohol consumption benefits heart health.

Insights into how cancer cells adapt and rewire their metabolism to achieve growth and survive was accompanied by a call for tools to study this on a nearly single-cell level, according to a new paper in Nature Communications.

Pea, potato, and pistachio milk? Supermarkets now sell multiple kinds of plant-based milks made from nuts, beans, grains, vegetables, or fruit. So how healthy are they?

Subvariant is rising in the region, but no sign of dramatic surge in cases that other nations have experienced.

Obtaining a medical marijuana card to use cannabis products to treat pain, anxiety, or depression symptoms led to the onset of cannabis use disorder while failing to improve symptoms, says a new study.

Experts trying to unravel why patients who recover from COVID-19 find they still have brain fog as part of their long COVID experience.

In a study of older adults, excessive daytime napping predicted an increased future risk of Alzheimer’s.

Researchers are now looking at a novel therapy for family caregivers that not only reduces depression, but also boosts well-being.

A new target for an old antibiotic is rooted in a decades-long effort to unlock the secrets of a lethal childhood disease.